BIOTRONIK Releases New Online Tool to Track MR Conditional Status of Implantable Devices
ProMRI SystemCheck Will Save Time and Streamline Workflow
BERLIN, Germany, Nov 24, 2014 – BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced the launch of ProMRI®SystemCheck, a new online tool for tracking the ProMRI status of implantable devices. A manufacturer of high quality ProMRI devices since 2010, BIOTRONIK offers the broadest portfolio of devices approved for use with MRIs, and continues to launch new pacemakers and implantable cardioverter-defibrillators (ICDs) every year. It is also the only company to allow heart failure patients with CRT devices to take advantage of MRI scans.
The simple online interface of ProMRI SystemCheck provides an easy reference for those looking to check if a certain pacemaker or ICD system is approved for MR scanning. After selecting the country in an auto-complete menu, users may input the names of pacemakers, ICDs, implantable cardiac monitors (ICMs) and leads. A single click then brings up information about whether these devices are MR conditional. The site also includes a crucial overview of scanning conditions for particular device and lead combinations, as well as required checks for each device before scanning.
“As a pioneer of ProMRI technology, BIOTRONIK has always placed the utmost value on innovative and high quality products and their ease of use,” said Wolf Ruhnke, Vice President at BIOTRONIK. “This is why we invest in innovative online tools like the ProMRI System Check, which enables users to quickly and conveniently obtain important information about our ProMRI devices and leads.”
BIOTRONIK ProMRI® technology enables patients with a pacemaker, implantable defibrillator, or cardiac resynchronization therapy defibrillator (CRT-D) or pacemaker (CRT-P) to undergo an MRI scan. BIOTRONIK has the broadest portfolio of cardiac devices approved for use with MRIs on the market and is the only company to allow heart failure patients with CRT devices to take advantage of MRI scans. ProMRI technology enables pacemaker patients, and now ICD patients, to undergo full-body scans. ICD patients may now also undergo ultra high field 3.0 T scans.
One of the world’s leading manufacturers of cardio- and endovascular medical devices, BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries by its global workforce of more than 5,600 employees. Several million patients have received BIOTRONIK implants designed to save and improve the quality of their lives, or have been treated with BIOTRONIK coronary and peripheral vascular intervention products. Since its development of the first German pacemaker in 1963, BIOTRONIK has engineered many innovations, including BIOTRONIK Home Monitoring®; the world’s first 4 F-compatible 200 mm peripheral stent; Orsiro, the industry’s first hybrid drug-eluting stent; and the world’s first implantable cardioverter defibrillators and heart failure therapy devices with
For more information, visit: www.biotronik.com
Senior Manager Communications & PR
BIOTRONIK SE & Co. KG
12359 Berlin, Germany
Tel. +49 (0) 30 68905 1414